BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 16409995)

  • 21. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
    Alonzo NC; Bayer BM
    J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
    Crain SM; Shen KF
    Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
    Rubovitch V; Pick CG; Sarne Y
    Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
    Zhao M; Joo DT
    Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence.
    Shen KF; Crain SM
    Brain Res; 2001 Nov; 919(1):20-30. PubMed ID: 11689159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance.
    Shavit Y; Wolf G; Goshen I; Livshits D; Yirmiya R
    Pain; 2005 May; 115(1-2):50-9. PubMed ID: 15836969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
    Crain SM; Shen KF
    Brain Res; 2001 Jan; 888(1):75-82. PubMed ID: 11146054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of mu-opioid and NMDA receptors in the development and maintenance of repeated swim stress-induced thermal hyperalgesia.
    Suarez-Roca H; Silva JA; Arcaya JL; Quintero L; Maixner W; Pinerua-Shuhaibar L
    Behav Brain Res; 2006 Feb; 167(2):205-11. PubMed ID: 16214233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
    Tiseo PJ; Inturrisi CE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
    Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
    Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y; Pasternak GW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of morphine-induced hyperalgesia in male and female rats.
    Holtman JR; Wala EP
    Pain; 2005 Mar; 114(1-2):62-70. PubMed ID: 15733632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
    Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice.
    Pol O; Puig MM
    Br J Pharmacol; 1997 Nov; 122(6):1216-22. PubMed ID: 9401789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
    Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
    Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
    Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid analgesia in the mouse: evidence for multiple receptors using beta-FNA.
    Sánchez-Blázquez P; Garzón J
    NIDA Res Monogr; 1986; 75():465-8. PubMed ID: 2828993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.